Pre-ejection period by radial artery tonometry supplements echo doppler findings during biventricular pacemaker optimization by Taha, Nima et al.
RESEARCH Open Access
Pre-ejection period by radial artery tonometry
supplements echo doppler findings during
biventricular pacemaker optimization
Nima Taha
1, Jing Zhang
2, Reza Rafie
1, Rupesh Ranjan
1, Salima Qamruddin
1 and Tasneem Z Naqvi
1*
Abstract
Background: Biventricular (Biv) pacemaker echo optimization has been shown to improve cardiac output however
is not routinely used due to its complexity. We investigated the role of a simple method involving computerized
pre-ejection time (PEP) assessment by radial artery tonometry in guiding Biv pacemaker optimization.
Methods: Blinded echo and radial artery tonometry were performed simultaneously in 37 patients, age 69.1 ± 12.8
years, left ventricular (LV) ejection fraction (EF) 33 ± 10%, during Biv pacemaker optimization. Effect of optimization
on echo derived velocity time integral (VTI), ejection time (ET), myocardial performance index (MPI), radial artery
tonometry derived PEP and echo-radial artery tonometry derived PEP/VTI and PEP/ET indices was evaluated.
Results: Significant improvement post optimization was achieved in LV ET (286.9 ± 37.3 to 299 ± 34.6 ms, p <
0.001), LV VTI (15.9 ± 4.8 cm to 18.4 ± 5.1 cm, p < 0.001) and MPI (0.57 ± 0.2 to 0.45 ± 0.13, p < 0.001) and in PEP
(246.7 ± 36.1 ms to 234.7 ± 35.5 ms, p = 0.003), PEP/ET (0.88 ± 0.21 to 0.79 ± 0.17, p < 0.001), and PEP/VTI (17.3 ±
7 to 13.78 ± 4.7, p < 0.001). The correlation between comprehensive echo Doppler and radial artery tonometry-PEP
guided optimal atrioventricular delay (AVD) and optimal interventricular delay (VVD) was 0.75 (p < 0.001) and 0.69
(p < 0.001) respectively. In 29 patients with follow up assessment, New York Heart Association (NYHA) class
reduced from 2.5 ± 0.8 to 2.0 ± 0.9 (p = 0.004) at 1.8 ± 1.4 months.
Conclusion: An acute shortening of PEP by radial artery tonometry occurs post Biv pacemaker optimization and
correlates with improvement in hemodynamics by echo Doppler and may provide a cost-efficient approach to
assist with Biv pacemaker echo optimization.
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Introduction
Prolongation of the pre-ejection period (PEP) and shorten-
ing of ejection time (ET) is the principal abnormality in
systolic heart failure (HF) patients with reduced left ventri-
cular ejection fraction (LVEF) [1]. PEP is comprised of
electromechanical delay (EMD) and isovolumic contrac-
tion time(IVCT). PEP/LVET is a validated measurement
of LV systolic performance and is independent of heart
rate [2,3]. Myocardial performance index (MPI) is a com-
bined measure of systolic and diastolic dysfunction [4],
which indicates the non-effective fraction and has been
widely used to estimate LV function and predict the prog-
nosis in HF patients [5].
Cardiac resynchronization therapy (CRT) also referred
to as atrial-synchronous biventricular (Biv) pacing, has
been an effective treatment for medically refractory HF
patients with ventricular dyssynchrony [1,6]. It is able to
shorten PEP, lengthen ET and reduce MPI thus leading
to an increase in LV effective fraction and stoke volume
[6,7]., Thus PEP, ET and MPI have been regarded as the
primary parameters to guide pacemaker optimization
[8,9]. Maximum hemodynamic improvement occurs at
an AV delay (AVD) that provides the most favorable pre-
load and an interventricular delay (VVD) that exhibits
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PEP for a dilated and failing heart [10-14].
In current practice, despite careful selection, as many
as 30-40% of patients do not respond to, or even dete-
riorate after CRT [15]. An important reason for such
high non-responder rate is lack of individual patient
pacemaker optimization. Echocardiography has been the
most recognized method for pacemaker optimization
and is endorsed by recent guidelines from American
Society of Echocardiography [10] and European Society
of Cardiology [11]. It has been shown to improve car-
diac output, [10,14,18] reduce hospitalization rates [16]
and improve New York Heart Association (NYHA) class
[17] in HF patients. Measurement of IVCT is not feasi-
ble by echo [18] and MPI measurement which requires
simultaneous assessment of mitral inflow and aortic out-
flow is difficult to obtain during online evaluation. LV
outflow velocity time integral (VTI) measurement is
more reliable, however difficult to obtain due to changes
in sample volume positioning. Assessment of multiple
Doppler parameters such as LV filling and ejection as
well as other Doppler parameters makes the procedure
more reliable however also makes it more time and
labor intensive. Furthermore it requires advanced skill
in echo Doppler and need for multispecialty collabora-
tion leading to underutilization of echo Doppler for
pacemaker optimization. Thus methods that are simple
and accurate for assisting echo Doppler techniques or
better still be usable as stand-alone methods may lead
to a wider adoption of pacemaker optimization.
We have recently shown the utility of phonocardio-
graphic S3 intensity in guiding pacemaker optimization,
however the technique appears to work best in those
with baseline S3 of > 5 [19]. The maximal dP/dt of the
radial pulse appears to be a valuable and reproducible
peripheral criterion of LV systolic performance in heart
failure [20]. In recent studies we have demonstrated the
potential value of ejection time measured by radial
artery tonometry in patients undergoing Biv pacemaker
optimization [21]. Recent enhancement with a wrist-
band tonometer instead of a hand held pen-like device
allows a hand-free operation and capture of radial artery
waveform without the variability associated with the
examiner hand motion. In addition the device now
allows an easy and quick assessment of PEP through
computerized analysis of a characteristic point ("foot of
the wave” or “timing point”) on the transcutaneous
radial artery waveform and the ECG-Q wave averaged
approximately 10 cardiac cycles. This value comprises of
two components, PEP of aortic waveform and the travel
time of the pressure wave from heart to radial artery
that remains constant in each patient.
We hypothesized that PEP by radial artery tonometry
m a yc o r r e s p o n dw i t hE Ta n dV T Ib ye c h oa n dm a yb e
used during Biv pacemaker optimization. This study was
designed to investigate the relationship of PEP measure-
ment by radial artery tonometry with echo derived ET
and LV VTI, during Biv pacemaker optimization.
Methods
Subjects
This study protocol was approved by the institutional
review board, and all subjects signed a written informed
consent before enrollment. The study group comprised
of 37 patients who were referred to our center for Biv
pacemaker optimization by their physicians from several
practices within a 50 mile radius. All patients had sinus
rhythm except 4 patients with atrial fibrillation. 21 of
these patients were also included in another optimiza-
tion and have been reported as part of the study group
in an earlier publication [19]. Patients were referred to
our tertiary care facility post CRT, mainly due to lack of
response from CRT, initial response to CRT followed by
recurrence of symptoms and rarely for worsening of
symptoms post CRT.
Study Protocol
New York Heart Association (NYHA) class was assessed
at baseline. Patient medication list was entered. The
pacemaker was interrogated using the algorithm
reported previously [19,21]. Underlying cardiac anatomy
and physiology were reviewed by echocardiogram in the
left lateral decubitus position before the procedure.
Blinded echocardiographic and radial artery tonometry
evaluation was performed simultaneously at baseline
and during pacemaker optimization. Two independent
experts performed tailored-echo and radial artery tono-
metry-PEP guided pacemaker optimization. Investigators
performing offline analysis were blinded to online
assessment of optimal AVD and VVD settings. Pace-
maker was programmed based on the results of the
online echocardiographic evaluation at the end of
procedure.
Tailored-Echo Guided Optimization
Examination was performed using a GE vivid 7 ultrasound
system (GE Vingmed Ultrasound, Horten, Norway), a vari-
able frequency phased array and low frequency (2.5 MHz)
transducer with conventional methods [22,23]. A highest
quality ECG signal was displayed on the ultrasound system
and 5 cardiac cycles were used for each data acquisition
for patients in sinus rhythm. For patients in atrial fibrilla-
tion or those with atrial or ventricular ectopics, 10 beats
were acquired in each view. PW Doppler sample volume
was placed 0.5-1 cm below the aortic valve to obtain the
LV ET and VTI. Frame rate was kept above 100 fps by
using single focus, narrow imaging sector, appropriate
depth and frame rate. The heart rate was kept constant
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myocardial segments and color Doppler was used for all
Doppler data acquisition. Raw data was stored digitally as
DICOM cine loops and transferred for offline analysis to a
customized dedicated workstation equipped with custom
built software (Echo PAC PC Dimension version 6.0.1) via
internet.
Cardiac chamber dimensions were obtained in end
systole in the parasternal long axis view. LVEF was mea-
sured by the biplane Simpson’s method [23]. LV VTI,
ET, diastolic filling time (FT) and MPI were measured
from pulsed wave Doppler. PEP was also measured by
echo as time interval from the onset of QRS complex
on the ultrasound monitor and onset of aortic ejection
on PW Doppler. Mitral regurgitation (MR) was graded
semi-quantitatively as mitral regurgitation jet area in
relation to left atrial area [ 2 4 ]a n da v e r a g e di na p i c a l
four, two and three chamber views. Pulmonary artery
peak systolic pressure (PAP) was measured by continu-
ous wave Doppler from tricuspid regurgitation jet [25].
AVD optimization was performed first and tested in
the available range of 30-300 ms. Ritter’s[ 2 6 ]m e t h o d
was used if feasible. In patients with mitral valve closure
occurring before pacemaker spike at the long AVD, Ritter
method was not used. AVD was changed in increments
of 10-20 ms depending on native AVD and mitral inflow
pattern [14]. PW Doppler of LV outflow tract was per-
formed and LV ejection duration and peak velocity was
measured at each AV and VVD. Optimal AVD was
selected based on the “best diastolic LV filling pattern”
and highest LV ejection duration and peak velocity, how-
ever in patients who had diastolic MR or tricuspid regur-
gitation, significant systolic MR, restrictive pulmonary
vein filling pattern, prominent pulmonary vein atrial
reversal and measureable and elevated PAP, these para-
meters were re-evaluated at optimal AVD to ensure max-
imum improvement in diastolic MR or tricuspid
regurgitation, least restrictive pulmonary vein filling pat-
tern (least S:D reversal, highest D wave deceleration time
and minimum pulmonary vein atrial reversal), least PAP
and minimum systolic MR along with optimum LV VTI
and diastolic filling pattern. In some patients mitral filling
time (FT) had to be compromised to minimize pulmon-
ary vein flow reversal while in others mitral inflow A
wave had to be truncated to avoid diastolic MR. LV VTI,
MPI and mitral inflow VTI were measured offline.
Optimal AV delay was programmed, and then VV
delay adjusted at the optimal AV delay. During VVD
optimization progressively increasing LV pre-excitation
was tested from 5 ms to 20 ms and right ventricular pre-
excitation tested from 5 ms to 20 ms. Progressively
increasing LV or right ventricular pre-excitation was
tested until maximum LV ejection duration was obtained.
In patients with mild or more MR and measurable PAP,
these were re-evaluated to ensure minimum values at
optimal VVD. Mitral inflow was re-evaluated after VVD
testing and AVD readjusted if required. Overall the pace-
maker setting was programmed to the AVD and VVD
combination exhibiting the maximum LVET, VTI, opti-
mum FT, minimum mitral regurgitation and pulmonary
artery pressure. This was called tailored-echo guided
“optimal setting”.
Radial artery tonometry-PEP Measurement
Radial artery pressure waveforms were acquired using a
high-fidelity pressure transducer (Millar Instruments,
Houston, TX) on the patient’s wrist by an elastic band
and connected to a radial artery tonometry pulse wave
velocity measurement system with a simultaneously
acquired 3-leads ECG signal using SphygmoCor
® device
( A t C o rM e d i c a lI n c ,L i s l e ,I L ) .T h es e n s o rc a r t r i d g e
used in the wrist strap tonometer is the same as that
used in the standard AtCor device. The only difference
is that the sensor cartridge is attached to an elastic strap
instead of incased in the plastic tube. Earlier comparison
studies within AtCor between the standard and wrist
strap tonometers showed no performance differences.
These were bench tests to confirm the sensitivity and
frequency response of the tonometer.
The radial artery waveform and ECG signals were
then digitized and analyzed using a custom software
program which determined the time interval from the
ECG-Q wave to the foot (onset) of the corresponding
radial artery waveform. To position the pressure trans-
ducer, the radial artery in each arm was palpated and
the wrist with the stronger pulse was used. A pillow was
placed under the arm to stabilize the wrist and the
transducer was placed against the skin at the location
where the operator felt the strongest signal from the
pulse. The strap of tonometer was adjusted to capture a
signal of adequate strength. The transducer was then
left in place without having to be held by the operator
and only needed minor adjustments in position during
the data acquisition.
Examination was carried out simultaneously with the
echocardiographic evaluation beginning 5-10 beats fol-
lowing each pacemaker adjustment. The computer screen
displayed a continuous radial artery waveform and lead-II
ECG wave. When 10-seconds of consistent and high
quality waveforms were displayed, a computer keystroke
captured and analyzed the recordings. Approximately 10
Q- radial artery foot time intervals were averaged to pro-
duce a mean value of the PEP for each record. Quality-
control information was reported simultaneously to
ensure consistent quality of the recordings and obtain
reliable results. PEP/ET and PEP/VTI indices were calcu-
lated based on the radial artery tonometry and echo data.
The optimal pacemaker setting by radial artery
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shortest PEP.
At the end of the optimization procedure the pace-
maker was programmed based on the results of the
online echocardiographic evaluation. NYHA class was
assessed at baseline and at 1 month post optimization.
Intraobserver and Interobserver Variability of PEP
Radial artery tonometry automated PEP measurements
from different AVDs were randomly selected (every 3rd
AVD observation) and a total of 46 PEP observations
from 5 randomly selected patients were measured for
intraobserver PEP variability, calculated as the difference
of each observation from the averagex100. Interobserver
variability was determined by difference of PEP from an
average of 5 readings at baseline among 2 observers in 5
subjects. The interobserver variability of PEP was 2.2 ±
2.3% and intraobserver variability was 1 ± 1.6%.
Statistical Analysis
Data are presented as mean values ± standard deviation
(SD). Continuous variables at baseline and post optimi-
zation were compared using paired two-tailed student’s
t-test. Wilcoxon signed-rank test was used for ordinally
scaled parameters like NYHA and mitral regurgitation
severity. Pearson correlation analyses were performed
between PEP and ET and VTI and between tailored-
echo and radial artery tonometry-PEP methods for opti-
mal AVD and VVD. Values of p < 0.05 was considered
statistically significant.
Results
Clinical characteristics of patients at baseline are shown
in Table 1. All patients had > 85% Biv pacing at base-
line. Patients had significant cardiac enlargement and
poor LV function. 37 (97%) had symptoms of HF and
19 (51.5%) had NYHA class III-IV at baseline. Satisfac-
tory signals by radial artery tonometry device were
obtained in all patients on first attempt. In one patient
with hypotension, more time was required to obtain
good quality radial artery waveform.
The shortest AVD and intrinsic AVD tested in the
study subjects were 66.6 ± 35.2 ms and 239.4 ± 53.7 ms
respectively during pacemaker interrogation. Baseline
pacemaker settings were AVD of 160 ± 53.7 ms and LV
offset of 8.4 ± 14.4 ms and optimal pacemaker settings
were AVD of 150.4 ± 67.2 ms and LV offset of 3.9 ± 6.7
ms (p = NS vs. baseline). A significant individual varia-
tion was present in the change in AVD setting in each
patient ranging from -180 ms to +150 ms AVD from
baseline. Baseline LV offs e tw a sp r o g r a m m e di n1 4
patients and RV offset in 2 patients. LV offset was
added in 5 patients and removed from 7 patients and
RV offset was added in 3 patients and removed in 1
patient. VVD was 0 ms post optimization in 21 patients.
An acute significant improvement was achieved post
optimization in echo Doppler and radial artery tonome-
try measurements as shown in Table 2. Figures 1 and 2
are representative PEP recordings in a study patient at
baseline and optimal AVD respectively. Data on each
patient for radial artery tonometry derived PEP and
Table 1 Clinical Characteristics of Study Subjects at Baseline (N = 37)
Age 69.1 ± 12.8 years
Gender Male/Female 26(70%)/11(30%)
NYHA I/II/III/IV 2.5 ± 0.8
2(5%)/16(43%)/14(38%)/5(14%)
Rhythm Sinus/Atrial Fibrillation 33(89%)/4(11%)
Etiology Ischemic/Non- Ischemic 25(68%)/12(32%)
QRS Duration 176 ± 19 ms
Other Clinical
Conditions
Hypertension
Diabetes Mellitus
22(66%)
12(36%)
Medications Diuretics
Beta-blockers
ACE-inhibitors
Amiodarone
28(75%)
29(78%)
26(70%)
13(35%)
Echocardiographic
Parameters
Left Ventricular Diastolic Diameter
Left Ventricular Systolic Diameter
Left Ventricular EDV(4C)
Left Ventricular ESV(4C)
Left Ventricular ESV(2C)
Left Ventricular EDV(2C)
Left Ventricular Ejection Fraction
Left Atrial Diameter (Antero-Posterior)
Left Atrial Volume
Left Atrial volume (Indexed)
6.3 ± 0.98 cm
5.3 ± 0.94 cm
218 ± 124 ml
153 ± 99 ml
224 ± 129 ml
156 ± 109 ml
33 ± 10%
5±1c m
108 ± 56 ml
53 ± 23 ml/m
2
ACE = Angiotensin converting enzyme inhibitor; EDV, end diastolic volume; ESV, end systolic volume.
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Parameter Baseline Post Optimization Percent Change P value
SBP (mm Hg) 110 ± 22
DBP (mm Hg) 62 ± 10
HR (bpm) 66 ± 7 67 ± 7 1 ± 7% 0.6
Echocardiographic
MR (grade) 1.5 ± 1.1 1.1 ± 0.93 -16.1 ± 26% 0.001
PAP (mmHg) 46 ± 10.8 38 ± 10.4 -18.5 ± 11.8% < 0.001
LV VTI (cm) 15.9 ± 4.8 18.4 ± 5 17.4 ± 16% < 0.001
ET (ms) 286.9 ± 37.3 299 ± 34.6 4.5 ± 4% < 0.001
FT (ms) 422.5 ± 96.2 435.2 ± 81.4 4.8 ± 13.2% 0.12
E/A ratio 1.8 ± 1.3 1.6 ± 1.3 4.8 ± 24.3% 0.094
MI VTI(cm) 19.3 ± 8.4 19.7 ± 8.8 1.97 ± 14.9% 0.473
MPI 0.57 ± 0.2 0.45 ± 0.13 -19.5 ± 10.8% < 0.001
PEP(ms) 136 ± 36 131.6 ± 40 -2.6 ± 17.6 0.24
Radial Artery Tonometry
PEP (ms) 246.7 ± 36.1 234.7 ± 35.5 -4.5 ± 9.5% 0.003
Radial Artery Tonometry and Echocardiographic
PEP/ET 0.88 ± 0.21 0.79 ± 0.16 -8.5 ± 9.5% < 0.001
PEP/VTI 17.3 ± 7 13.7 ± 4.7 -17.5 ± 13.5% < 0.001
MR = Mitral Regurgitation; PAP = Pulmonary Artery Pressure; LV VTI = Left Ventricular Outflow Velocity Time Integral; FT = LV Filling Time; ET = LV Ejection Time;
PEP = Pre-ejection Period; MPI = Myocardial Performance Index; MR Grade: 0 = None; 0.5 = Trace; 1 = Mild; 1.5 = Mild to Moderate; 2 = Moderate; 3 = Moderate
to Severe; 4 = Severe.
Figure 1 A Case Example Showing Radial Artery PEP Measurement at Baseline. A case example of a patient showing radial artery-PEP
measurement at baseline.
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VTI and MPI by echo Doppler in each study subject is
shown in Figure 4.
A significant correlation was found between baseline
ET and radial artery tonometry derived PEP (r = -0.44,
p < 0.001) and between baseline VTI and radial artery
tonometry derived PEP (r = -0.27, p < 0.001). PEP by
echo could be measured in 31 out of 37 study patients.
This was due to difficulty in delineating onset of QRS in
all patients on the ultrasound rhythm tracing. Figure 5
shows echo PW Doppler images of LV outflow showing
corresponding changes in PEP by echo during native
conduction, during baseline biv pacemaker setting and
during optimal AVD settings. A significant correlation
was found between PEP measured by echo and PEP
measured by radial artery tonometry at baseline (r =
0.44, p < 0.001) and optimal (r = 0.62, p < 0.001) pace-
maker settings.
We used PEP/ET and PEP/VTI as a surrogate for MPI
- a validated parameter for LV systolic and diastolic
function. Data on PEP/VTI, PEP/ET at baseline and
optimal pacemaker settings using a combination of
radial artery tonometry and echo measurements is
shown in Figure 6.
Figure 7 shows the correlation between comprehensive
echo Doppler and radial artery tonometry -PEP guided
optimal AVD (r = 0.75, p < 0.001) and VVD (r = 0.69,
p < 0.001).
Radial artery tonometry derived PEP trended to be
higher (258 ± 35 ms) in those class III and IV symptoms
(n = 19) compared to those with NYHA class I and II
symptoms (n = 18, 235 ± 34 ms, p = 0.05). PEP was
shortened to a comparable degree by pacemaker optimi-
zation in both NYHA class I-II and III-IV patients to
234 ± 42 and 236 ± 30 ms respectively.
We also evaluated baseline echocardiographic findings
among those with baseline NYHA class of I and II (Gp I)
versus those with NYHA class III and IV (Gp II) and the
data is shown in Table 3. As shown a significant
improvement in most echo Doppler parameters occurred
in both groups of patients.
Follow-up
Patients were followed at 1.8 ± 1.4 months post optimi-
zation. 3 patients, one with severe ventricular ectopy
requiring reversal to original pacemaker settings, 1 with
recurrent hospitalizations for end stage renal disease
and one wheelchair bound from multiple sclerosis were
Figure 2 A Case Example showing Radial Artery PEP Measurement After Echo-Guided Pacemaker Optimization. Radial artery tonometry
PEP measurement at optimal AVD in the same patient showing shortening of PEP compared to baseline. PEP, pre-ejection period.
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class reduced from 2.5 ± 0.8 to 2 ± 0.9 (p = 0.003).
NYHA improved in 18 (62%), did not change in 7 (24%)
and deteriorated in 4 (14%) patients.
Discussion
The major finding of this study is that an acute PEP
shortening by radial artery tonometry occurs with opti-
mization of AVD and VVD and correlates with
improvement in hemodynamics measured by echocar-
diography. PEP predicted optimal VVD and optimal
AVD in majority of patients. Ratio of PEP with echocar-
diographic LV ejection parameters - ET and VTI, corre-
sponded to MPI assessment and shortened during
pacemaker optimization. Findings from our study sug-
gest that radial artery tonometry-PEP may be used in
conjunction with echo derived ET or VTI to guide AVD
optimization. The shortening of PEP was more pro-
nounced in patients with NYHA class III and IV symp-
toms in whom PEP should be tested as a stand-alone
method to guide pacemaker optimization.
While there was concordance between echo derived
optimal AVD and radial artery tonometry derived PEP in
majority of patients, some patients had significant discre-
pancy. This could be related to the use of comprehensive
echo Doppler parameters to guide echo optimization
compared to only PEP by radial artery tonometry. A ran-
domized study comparing echo vs. PEP guided optimiza-
tion and effect on acute and chronic improvement in
cardiac structural and functional parameters would be
required to compare the two techniques.
MPI is preload and afterload dependent and has diag-
nostic and prognostic power in HF patients [4,27,28].
Echocardiographic studies have shown that PEP and
PEP/ET ratio can be used instead of MPI to assess car-
diac performance [1,29,30]. We found PEP/VTI and PEP/
ET derived from radial artery tonometry (PEP) and echo
Doppler (VTI and ET) to correspond to MPI as mea-
sured by echo reflects the accuracy of PEP measured by
radial artery tonometry. We have measured ET by radial
artery tonometry in a prior study and showed good cor-
relation with echo derived ET [21]. Hence PEP/ET can
be derived entirely from radial artery tonometry once
software modification allows simultaneous measurement
of both PEP and ET. We found echocardiographic assess-
ment of PEP less feasible due to inadequate QRS signal
Figure 3 Effect of Biventricular Pacemaker Optimization on PEP Measured by Radial Artery Tonometry and LV ET Measured by Echo
Doppler. Effect of biventricular pacemaker optimization on PEP measured by radial artery tonometry and LV ET measured by echo Doppler.
Baseline and optimal PEP (left panel) and baseline and optimal ET measured by echo Doppler (right panel) are shown in each study subject. PEP,
pre-ejection period; ET, ejection time
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Page 7 of 12Figure 4 Effect of Biventricular Pacemaker Optimization on VTI and MPI Measured by Echo Doppler. Effect of biventricular pacemaker
optimization on LV VTI and MPI measured by echo Doppler. Baseline and optimal LV VTI (left panel) and baseline and optimal MPI (right panel)
measured by echo are shown in each study subject. VTI, velocity time integral; MPI, myocardial performance index. MPI was feasible in 33
patients due to atrial fibrillation in 4 patients.
Figure 5 Effect of Biventricular Pacemaker Optimization on PEP Measured by Echo Doppler. Echo determined PEP in the same patient as
in Figure 1 during native AV conduction at an AVD of 300 ms in panel A, baseline AVD of 200 ms in panel B, AVD of 180 ms in panel C and
optimal AVD of 160 ms in panel C. Mean PEP was 184 ms in A and 171 ms at baseline AVD of 200 ms during biv pacing in B. AVD of 180 ms in
C and optimal AVD of 160 ms in D led to shortening of PEP to 154 ms. Note difficulty in determining QRS onset in panel A.
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Page 8 of 12Figure 6 Effect of Biventricular Pacemaker Optimization on PEP measured by Radial Artery Tonometry and Echo Doppler.E f f e c to f
biventricular pacemaker optimization on PEP/VTI (left panel) and on PEP/ET (right panel) measured by radial artery tonometry (PEP) and by echo
Doppler (VTI and ET) are shown in each study subject. PEP, pre-ejection period; VTI, velocity time integral; ET, ejection time
Figure 7 Correlation between Echo Doppler and Radial Artery Tonometer for Optimal Pacemaker Settings. Correlation between optimal
AVD determined by radial artery tonometry and by echo Doppler (left panel) and between optimal VVD determined by radial artery tonometry
and by echo Doppler (right panel). In 21 patients optimal VVD was 0 ms by both echo Doppler method and by applanation tonometry. Hence
the dot at point 0 represents 21 patients instead of 1 patient. Similarly more than 1 patient (as shown in Table 2) who have identical VVD and
AVD by echo and tonomtery are shown by a single data point.
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averaged over 10 beats and was a computerized measure
as opposed to manual measurement of echo PEP from 3-
5 Doppler tracings. Moreover onset of aortic ejection
click may or may not be readily visible if the pulsed wave
sample volume is placed in the desired location to mea-
sure stroke volume and it may be subject to gain artifacts
and to Doppler filter settings. A higher PEP by radial
artery tonometry in those with a higher NYHA class in
our study group indicates that radial artery PEP is a reli-
able marker of LV dysfunction. Although significant
acute improvement occurred in patients with NYHA I-II
as well as III-IV patients, greater improvement in LV
VTI occurred in those with NYHA class III and IV com-
pared to those with NYHA class I and II and significant
PEP improvement occurred only in patients with NYHA
class III and IV suggesting that optimization by echo
Doppler or PEP may be maximally useful in this group of
patients. In contrast to echocardiographic studies, operat-
ing radial artery tonometry device is much simpler and
less labor intensive and may play a potentially important
role in assisting echo Doppler and other algorithms for
multiple inter and intraventricular delay changes during
pacemaker programming in future generation pace-
makers. In particular it may have a role in determining
optimal LV-RV delay and LV-LV delay in pacemakers
with multiple LV and RV electrodes. Evaluation of LV
performance during a single component of cardiac cycle
may by itself not provide adequate evaluation of global
cardiac function, and evaluation of LV performance in
various systolic and diastolic phases is likely required for
determination of optimal AV and VV delays. PEP was
shown to correlate well with myocardial contractility pro-
vided that LV end diastolic pressure did not change sig-
nificantly [3]. In this respect, we have shown that
phonocardiographic S3 intensity correlates with echo
Doppler measures during pacemaker optimization [19].
Radial artery PEP and better still PEP/ET may be useful
in conjunction with assessment of S3 intensity for pace-
maker optimization given that PEP and ET determine LV
systolic performance during isovolumic and ejection sys-
tolic phase whereas S3 intensity is a marker of LV diasto-
lic filling and diastolic pressure.
Many different echo Doppler parameters have been
used in the literature for pacemaker optimization. These
include mitral inflow VTI, filling time, E/A ratio, decel-
eration time, aortic outflow VTI, ejection duration and
MR Dp/Dt. There is variability in appropriate pace-
maker settings depending on which of these echo Dop-
pler parameters is selected. It is to be noted that in
almost all earlier CRT studies echo guided pacemaker
optimization was used using mitral inflow or aotic out-
flow method. As shown in our study, comprehensive
echo Doppler optimization does have a role in the man-
agement of patients - especially non responders post
CRT, however it is time consuming and requires exper-
tise. It is therefore important to find simple non invasive
methods for pacemaker optimization. Radial artery tono-
metry technique is a simple, non invasive, fast, reprodu-
cible method of assessing PEP that can be rapidly
mastered by hospital/ECG/echo staff. It eliminates
operator dependent inter observer variability inherent in
many echo Doppler techniques due to operator and
patient related factors. Use of PEP by radial artery
Table 3 Effect of Echocardiography Guided Biventricular Pacemaker Optimization on Cardiac Hemodynamics and
Radial Artery Tonometry Derived PEP in NYHA Class I and II (Group I) vs. Class III and IV (Group II) Patients
Parameter Baseline Post Opt P value Δ%
Group I LV-VTI 16.8 ± 3.8 18.5 ± 4.1* 0.001 11.3
Group II LV-VTI 15 ± 5.6 18.3 ± 6.1* < 0.001 24†
Group I LV-ET 298.8 ± 36.4 311.3 ± 30.9* < 0.001 4.6
Group II LV-ET 275.5 ± 35.3 287.5 ± 34.7* < 0.001 4.5
Group I FT 403.7 ± 84.2 420.8 ± 53.2 0.24 6.8
Group II FT 440.2 ± 105.5 449 ± 100.8 0.33 2.8
Group I MPI 0.57 ± 0.2 0.45 ± 0.15* < 0.001 -19.6
Group II MPI 0.58 ± 0.18 0.45 ± 0.12* < 0.001 -19.5
Group I MR 1.4 ± 1.1 1 ± 0.9* 0.02 -13.7
Group II MR 1.6 ± 1.1 1.2 ± 0.9* 0.02 -22
Group I PAP 39.5 ± 10.1 33.1 ± 9.9* < 0.001 -17.6
Group II PAP 52.3 ± 7.2† 42.3 ± 9* < 0.001 -19.4
Group I PEP 235 ± 34 234 ± 42 0.48 -0.6
Group II PEP 258 ± 35 236 ± 30 < 0.001 -8.2†
Gp I, n = 18, Gp II, n = 19,*p < 0.05 vs. baseline; †p < 0.05 vs. group I; Δ% = Difference% = (Post Optimization-Baseline)/Baseline; LV-VTI (cm) = Left Ventricular
Velocity Time Integral; ET (ms) = Left Ventricular Ejection Time; FT (ms) = Left Ventricular Filling Time; MPI = Myocardial Performance Index; MR = Mitral
Regurgitation; PAP (mmHg) = Pulmonary Artery Pressure; PEP = Pre-Ejection Time (ms). MR Grade: 0 = None; 0.5 = Trace; 1 = Mild; 1.5 = Mild to Moderate; 2 =
Moderate. P = 0.06 for E wave and 0.08 for DT vs. baseline.
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Page 10 of 12tonometer needs to be tested in randomized prospective
studies for its value in pacemaker optimization.
Limitations
Echo Doppler method of pacemaker optimization we
describe is time intensive. The QRS width changes in
response to AVD and VVD changes may influence PEP
measurement independent of mechanical effects of pace-
maker changes. We chose the optimal pacemaker set-
tings based on results of echo evaluation. We did not
use radial artery tonometry as the primary method of
pacemaker optimization and this utility of the device
needs to be tested against echocardiography in prospec-
tive randomized studies. Our patients’ baseline pace-
maker settings were in a wide range at baseline and not
at “out of box settings”. This is because patients had
pacemaker programming performed by their treating
physicians by using various methods and algorithms.
Conclusion
Our findings indicate significant concordance among
echocardiographic and radial artery tonometry methods in
determining optimal AVD and VVD. The additive clinical
impact of the PEP optimization approach over a conven-
tional comprehensive hemodynamic assessment using
echo-Doppler techniques during optimization as a stand-
alone method needs to be addressed in future studies.
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